ArticleNews reportPHN-05182026-11-01 19:42 CT

Review of 28 studies links GLP-1 to changes in PCOS — News-Medical

Source · UA.NEWS

TLDR

Nova Southeastern University researchers reported that a review of 28 studies suggests GLP-1 receptor agonists may improve some hormonal indicators and menstrual function in women with PCOS. Findings on ovulation, fertility and pregnancy remain limited, and researchers could not separate direct drug effects from changes associated with weight loss and improved metabolic status.

01—Key points

01Researchers reported reductions in several androgen indicators; findings on acne and hirsutism were inconsistent.
02Of 13 studies assessing menstrual function, three reported improved frequency or regularity, primarily with substantial weight loss; other findings varied.
03Small samples, short follow-up and heterogeneous studies limit conclusions; the review did not assess pregnancy safety.

Why it matters Editorial

The review suggests possible reproductive effects of GLP-1 therapies in PCOS, but does not establish whether these effects are independent of weight loss.

Read the original at UA.NEWS↗

Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.